NK2-receptor mediated contraction in monkey, guinea-pig and human airway smooth muscle

Neuropeptides

Volumn 33, Issue 1, 1999, Pages 27-34

  Rizzo, C A ^a   Valentine, A F ^a   Egan, R W ^a   Kreutner, W ^a   Hey, J A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROKININ 2 RECEPTOR; OSANETANT; SAREDUTANT;

ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CRYOPRESERVATION; DRUG EFFECT; GUINEA PIG; HUMAN; HUMAN TISSUE; MEDIATOR RELEASE; MONKEY; MUCOCILIARY CLEARANCE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATORY EPITHELIUM; SMOOTH MUSCLE CONTRACTION;

ANIMALIA; BRONCHUS; CAVIA PORCELLUS; MACACA FASCICULARIS; PRIMATES; SUS SCROFA;

EID: 0033082680     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0027     Document Type: Article

References (24)

1. Wegman D H, Fine L J. Occupational and environmental medicine. JAMA 1996; 275 (23): 1831-1832.
2. Piedimonte G. Tachykinin peptides, receptors and peptidases in airway disease. Exp Lung Res 1995; 21: 809-834.
3. Ichinose M, Nakajima N, Takahashi T, Yamuchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992; 340: 1248-1251.
4. 2 receptor antagonist SR 48968 on neurokinin A-induced bronchoconstriction in asthmatics. Eur Respir J 1996; 9 (Suppl. 23): 289s.
5. 2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs. J Pharm Exp Ther 1992; 262 (1): 403-408.
6. Naline E, Devillier P, Drapeau G et al. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis 1989; 140: 679-680.
7. 2) receptors. Am Rev Respir Dis 1992; 146: 1177-1181.
8. 2-receptors. Neuropeptides 1995; 29: 281-292.
9. Maggi C A, Patacchini R, Quartara L, Rovero P, Santicioli P. Tachykinin receptors in the guinea pig isolated bronchi. Eur J Pharmacol 1991; 197: 167-174.
10. Ellis J L, Undem B J, Kays J S, Ghanekar S V, Barthlow H G, Buckner C K. Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. J Pharm Exp Ther 1993; 267 (1): 95-101.
11. 1 receptors on human isolated small bronchi. Am J Physiol 1996; 271 (15): L763-L767.
12. Krell R D. Pharmacologic characterization of isolated rhesus monkey bronchial smooth muscle. J Pharm Exp Ther 1979; 211 (2): 436-443.
13. Nagai H, Kondo M, Koda A et al. Responses of isolated japanese monkey tracheal muscle to allergic mediators. Int Arch Allergy Immunol 1992; 98: 70-75.
14. Ellis P, Muller-Schweinitzer E. Maintenance of functional activity of human pulmonary arteries after cryopreservation. Br J Pharmacol 1991; 103: 1377-1380.
15. Ellis J L, Undem B J. Role of cysteinyl-leukotrienes and histamine in mediating intrinsic tone in isolated human bronchi. Am J Respir Crit Care Med 1994; 149: 118-122.
16. Tallarida R J. I. Pharmacologic methods for identification of receptors. Life Sci 1988; 43 (26): 2169-2176.
17. Tallarida R J, Murray R B. Manual of Pharmacologic Calculations with Computer Programs, New York: Springer-Verlag. 1981.
18. Patacchini R, Maggi C A. Tachykinin receptors and receptor subtypes. Arch Int Pharmacodyn 1995; 329: 161-184.
19. McLean S, Ganong A, Seymour P A, et al. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther 1993; 267 (1): 472-479.
20. Emonds-Alt X, Bichon D, Ducoux J P et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci 1995; 56 (1): PL 27-32.
21. Patacchini R, Bartho L, Holzer P, Maggi C A. Activity of SR 142801 at peripheral tachykinin receptors. Eur J Pharmacol. 1995; 278: 17-25.
22. Sarria B, Naline E, Cortijo J et al. Functional biochemical and morphological studies on human bronchi after cryopreservation. Br J Pharmacol 1995; 116: 2569-2574.
23. Kudlacz E M, Shatzer S A, Knippenberg R W et al. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist. J Pharmacol Exp Ther 1996; 277 (2): 840-851.
24. Mauser P J, Skeans S, Ritacco G, Fernandez X, Chapman R W. Comparison of the bronchoconstrictor response to histamine, neurokinin A and substance P in cynomolgus monkeys. Respir Crit Care Med 1997; 155 (4): A483.